We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$408M
AUM Growth
+$45.4M
Cap. Flow
+$36.4M
Cap. Flow %
8.92%
Top 10 Hldgs %
22.24%
Holding
536
New
184
Increased
108
Reduced
56
Closed
65

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$4.5M
2
CSCO icon
Cisco
CSCO
+$4.49M
3
DD icon
DuPont de Nemours
DD
+$4.35M
4
CMCSA icon
Comcast
CMCSA
+$4.29M
5
MDT icon
Medtronic
MDT
+$4.24M

Top Sells

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$4.27M
2
IBM icon
IBM
IBM
+$4.16M
3
BSX icon
Boston Scientific
BSX
+$4.09M
4
MCD icon
McDonald's
MCD
+$4.04M
5
FISV
Fiserv Inc
FISV
+$3.54M

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 12.58%
3 Financials 10.68%
4 Communication Services 8.67%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHGG icon
301
Chegg
CHGG
$98.4M
$3K ﹤0.01%
+73
New +$2.2K
CSL icon
302
Carlisle Companies
CSL
$15.2B
$3K ﹤0.01%
+12
New +$2.81K
EYE icon
303
National Vision
EYE
$1.8B
$3K ﹤0.01%
+66
New +$2.68K
FATE icon
304
Fate Therapeutics
FATE
$290M
$3K ﹤0.01%
78
+17
+28% +$658
FIVE icon
305
Five Below
FIVE
$12.8B
$3K ﹤0.01%
+18
New +$3K
FND icon
306
Floor & Decor
FND
$6.39B
$3K ﹤0.01%
+33
New +$3.34K
ICLR icon
307
Icon
ICLR
$12.4B
$3K ﹤0.01%
+12
New +$3.01K
IFRA icon
308
iShares US Infrastructure ETF
IFRA
$4.56B
$3K ﹤0.01%
+75
New +$2.8K
KHC icon
309
Kraft Heinz
KHC
$29.6B
$3K ﹤0.01%
77
LLY icon
310
Eli Lilly
LLY
$1.06T
$3K ﹤0.01%
+10
New +$2.57K
MANH icon
311
Manhattan Associates
MANH
$11.1B
$3K ﹤0.01%
+24
New +$3.21K
MFC icon
312
Manulife Financial
MFC
$74.1B
$3K ﹤0.01%
154
MKSI icon
313
MKS Inc
MKSI
$19.7B
$3K ﹤0.01%
+23
New +$3.57K
MMSI icon
314
Merit Medical Systems
MMSI
$5.24B
$3K ﹤0.01%
+42
New +$2.52K
MTN icon
315
Vail Resorts
MTN
$5.23B
$3K ﹤0.01%
+10
New +$2.72K
NBIX icon
316
Neurocrine Biosciences
NBIX
$16.2B
$3K ﹤0.01%
+28
New +$2.37K
NOVT icon
317
Novanta
NOVT
$5.82B
$3K ﹤0.01%
+23
New +$3.26K
NXST icon
318
Nexstar Media Group
NXST
$5.74B
$3K ﹤0.01%
+16
New +$2.78K
PFGC icon
319
Performance Food Group
PFGC
$18B
$3K ﹤0.01%
+65
New +$3.19K
PLNT icon
320
Planet Fitness
PLNT
$4.05B
$3K ﹤0.01%
+30
New +$2.6K
POWA icon
321
Invesco Bloomberg Pricing Power ETF
POWA
$182M
$3K ﹤0.01%
+43
New +$2.97K
PTC icon
322
PTC
PTC
$16B
$3K ﹤0.01%
+30
New +$3.37K
RGEN icon
323
Repligen
RGEN
$9B
$3K ﹤0.01%
+18
New +$3.42K
SCHD icon
324
Schwab US Dividend Equity ETF
SCHD
$105B
$3K ﹤0.01%
105
SONO icon
325
Sonos
SONO
$1.83B
$3K ﹤0.01%
+90
New +$2.39K

Similar funds

Providence Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Providence Capital Advisors held 536 positions worth $408M, up 13% from $363M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Providence Capital Advisors deployed $36.4M of net new capital in Q1 2022, opening 184 new positions and adding to 108 existing holdings. Its largest new stake was DuPont de Nemours: 44,534 shares worth $4.09M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dow Inc, an estimated $4.27M trimmed.

  • Providence Capital Advisors's largest Q1 2022 buy was DuPont de Nemours: 44,534 shares worth $4.09M.
  • Providence Capital Advisors added most to Linde in Q1 2022, an estimated $4.5M increase.
  • Providence Capital Advisors's biggest Q1 2022 reduction was Dow Inc, cutting an estimated $4.27M.
  • Providence Capital Advisors fully exited Boston Scientific in Q1 2022, selling an estimated $4.09M.
  • Providence Capital Advisors's ten largest holdings make up 22% of its $408M portfolio in Q1 2022.
  • Providence Capital Advisors opened 184 new positions and closed 65 in Q1 2022.
  • Providence Capital Advisors's portfolio value rose 13% quarter-over-quarter to $408M.

Based on Providence Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.